ICU Medical Inc

Day range

$163.15 – $170.00

Open

$169.64

Prev close

$168.65

Volume

216.56K

Market cap

$4.1B

Shares out

24.99M

P/E

136.12

P/S

1.90

P/B

1.90

P/FCF

26.80

ROE

1.4%

ROA

0.8%

Debt/Equity

0.57

Div yield

0.00%

As of Oct 30, 2026

• Annual meeting resultsMay 18, 2026

  At the Annual Meeting held on May 13, 2026, the following proposals were voted on by the Company's stockholders, and the results were as set forth below: [Proposal 1 through Proposal 7 with voting results for director elections, auditor ratification, executive compensation approval, charter amendments, and stockholder proposals].

• Executive compensation changeFeb 20, 2026

  On February 20, 2026, the Compensation Committee of the Board of Directors of ICU Medical, Inc. adopted and approved an amendment to the ICU Medical, Inc. Executive Severance Plan...Effective as of December 31, 2025, the Amendment amends the Executive Severance Plan to extend the expiration date by three years to December 31, 2028.

• Annual meeting resultsMay 14, 2025

  At the Annual Meeting held on May 13, 2025, the following proposals were voted on by the Company's stockholders, and the results were as set forth below: Proposal 1. Election of directors... Proposal 2. Approve an Amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan... Proposal 3. Ratification of the appointment of Deloitte & Touche LLP... Proposal 4. Approve, on an advisory basis, the Company's named executive officer compensation... Proposal 5. Approve, on an advisory basis, a stockholder proposal to adopt simple majority voting.

• Executive officer appointmentOct 2, 2024

  On September 30, 2024, the Board of Directors of ICU Medical, Inc. (the "Company") appointed Mr. Daniel Woolson, 48, as President of the Company, effective immediately. Mr. Woolson has served as Corporate Vice President, General Manager – Infusion Systems since 2017.

• Annual meeting resultsMay 16, 2024

  At the 2024 Annual Meeting of stockholders of ICU Medical, Inc. (the "Company") held on May 15, 2024, the following proposals were voted on by the Company's stockholders, and the results were as set forth below: Proposal 1. Election of directors... Proposal 2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024... Proposal 3. Approve the advisory vote on the Company's named executive officer compensation.

Days to cover

7.8

Short interest

1.71M

Avg volume

219.1K

As of Oct 15, 2026 · reported to FINRA twice monthly.

• Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
  positiveZacks Investment Research· Oct 12, 2026
• China Airway Management Market Forecast to 2033 - Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth Opportunities
  neutralGlobeNewswire Inc.· Oct 9, 2026
• ICU Medical CFO Brian Bonnell Sells 9,307 Shares
  positiveThe Motley Fool· Sep 16, 2026
• Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA
  positiveGlobeNewswire Inc.· Sep 7, 2026
• ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out.
  negativeThe Motley Fool· Jun 10, 2026